Submission for OMB Review; Comment Request, 14800-14801 [2013-05331]
Download as PDF
14800
Federal Register / Vol. 78, No. 45 / Thursday, March 7, 2013 / Notices
Department of Health and Human
Services, Office of HIV/AIDS and
Infectious Disease Policy, 200
Independence Avenue SW, Room 443–
H, Washington, DC 20201.
FOR FURTHER INFORMATION CONTACT: Ms.
Caroline Talev, Public Health Assistant,
PACHA, Department of Health and
Human Services, 200 Independence
Avenue SW, Room 443–H, Washington,
DC 20201; (202) 205–1178. More
detailed information about PACHA can
be obtained by accessing the Council’s
Web site www.aids.gov/pacha.
SUPPLEMENTARY INFORMATION: The
PACHA was established to provide
advice, information, and
recommendations to the Secretary
regarding programs and policies
intended to promote effective
prevention of HIV disease and AIDS.
The functions of the Council are solely
advisory in nature.
The Council consists of not more than
25 members. Council members are
selected from prominent community
leaders with particular expertise in, or
knowledge of, matters concerning HIV
and AIDS, public health, global health,
philanthropy, marketing or business, as
well as other national leaders held in
high esteem from other sectors of
society. Council members are appointed
by the Secretary or designee, in
consultation with the White House
Office on National AIDS Policy.
Pursuant to advance written agreement,
Council members shall receive no
stipend for the advisory service they
render as members of PACHA. However,
as authorized by law and in accordance
with federal travel regulations, PACHA
members may receive per diem and
reimbursement for travel expenses
incurred in relation to performing duties
for the Council.
This announcement is to solicit
nominations of qualified candidates to
fill current vacancies on the PACHA.
Nominations
In accordance with the PACHA
charter, persons nominated for
appointment as members of the PACHA
should be among prominent community
leaders and authorities with particular
expertise in, or knowledge of, matters
concerning HIV and AIDS, public
health, global health, philanthropy,
marketing or business, as well as other
national leaders held in high esteem
from other sectors of society. The
following information should be
included in the package of material
submitted for each individual being
nominated for consideration of
appointment:
a. The name, return address, daytime
telephone number, and affiliation(s) of
the individual being nominated, the
basis for the individual’s nomination,
and a statement bearing an original
signature of the nominated individual
that, if appointed, he or she is willing
to serve as a member of the Council;
b. the name, return address, and
daytime telephone number at which the
nominator may be contacted.
Organizational nominators must
identify a principal contact person; and
c. a copy of a current resume or
curriculum vitae for the nominated
individual.
Individuals can nominate themselves
for consideration of appointment to the
Council. All nominations must include
the required information. Incomplete
nominations will not be processed for
consideration. The letter from the
nominator and certification of the
nominated individual must bear original
signatures; reproduced copies of these
signatures are not acceptable.
The Department is legally required to
ensure that the membership of HHS
federal advisory committees is fairly
balanced in terms of points of view
represented and the functions to be
performed by the advisory committee.
Every effort is made to ensure that the
views of women, all ethnic and racial
groups, and people with disabilities are
represented on HHS federal advisory
committees and, therefore, the
Department encourages nominations of
qualified candidates from these groups.
The Department also encourages
geographic diversity in the composition
of the Council. Appointment to the
Council shall be made without
discrimination on the basis of age, race,
ethnicity, gender, sexual orientation,
disability, and cultural, religious, or
socioeconomic status. The Standards of
Ethical Conduct for Employees of the
Executive Branch are applicable to
individuals who are appointed as
members of the Council.
Dated: February 22, 2013.
B. Kaye Hayes,
Executive Director, Presidential Advisory
Council on HIV/AIDS.
[FR Doc. 2013–05218 Filed 3–6–13; 8:45 am]
BILLING CODE 4150–43–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
Submission for OMB Review;
Comment Request
Title: Community Services Block
Grant (CSBG) Program Model Plan
Application.
OMB No.: 0970–0382.
Description: Sections 676 and 677 of
the Community Services Block Grant
Act require States, including the District
of Columbia and the Commonwealth of
Puerto Rico, Tribes, Tribal organizations
and U.S. territories applying for
Community Services Block Grant
(CSBG) funds to submit an application
and plan (Model Application Plan). The
application plan must meet statutory
requirements prior to being funded with
CSBG funds. Applicants have the option
to submit a detailed application
annually or biannually. Entities that
submit a biannual application must
provide an abbreviated application the
following year if substantial changes to
the initial application will occur. OMB
approval is being sought.
Respondents: State Governments,
including the District of Columbia and
the Commonwealth of Puerto Rico,
Tribal Governments, Tribal
Organizations, and U.S. territories.
ANNUAL BURDEN ESTIMATES
Number of
respondents
emcdonald on DSK67QTVN1PROD with NOTICES
Instrument
Model State CSBG Application .......................................................................
Model Indian Tribes & Tribal Organizations CSBG Application ......................
Estimated Total Annual Burden
Hours: 860.
VerDate Mar<15>2010
14:43 Mar 06, 2013
Jkt 229001
56
30
Additional Information: Copies of the
proposed collection may be obtained by
writing to the Administration for
PO 00000
Frm 00038
Fmt 4703
Sfmt 4703
Number of
responses per
respondent
1
1
Average
burden hours
per response
10
10
Total burden
hours
560
300
Children and Families, Office of
Planning, Research and Evaluation, 370
L’Enfant Promenade SW., Washington,
E:\FR\FM\07MRN1.SGM
07MRN1
Federal Register / Vol. 78, No. 45 / Thursday, March 7, 2013 / Notices
DC 20447, Attn: ACF Reports Clearance
Officer. All requests should be
identified by the title of the information
collection. Email address:
infocollection@acf.hhs.gov.
OMB Comment: OMB is required to
make a decision concerning the
collection of information between 30
and 60 days after publication of this
document in the Federal Register.
Therefore, a comment is best assured of
having its full effect if OMB receives it
within 30 days of publication. Written
comments and recommendations for the
proposed information collection should
be sent directly to the following: Office
of Management and Budget, Paperwork
Reduction Project, Fax: 202–395–7285,
Email:
OIRA_SUBMISSION@OMB.EOP.GOV,
Attn: Desk Officer for the
Administration for Children and
Families.
Robert Sargis,
Reports Clearance Officer.
[FR Doc. 2013–05331 Filed 3–6–13; 8:45 am]
BILLING CODE 4184–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2012–N–1046]
Veterinary Oversight of Antimicrobial
Use in Livestock: Impact on
Stakeholders; Public Meetings;
Request for Comments
AGENCY:
Food and Drug Administration,
HHS.
Notice of public meetings;
request for comments.
emcdonald on DSK67QTVN1PROD with NOTICES
ACTION:
SUMMARY: The Food and Drug
Administration (FDA) is announcing
plans for five meetings to provide an
opportunity for public dialogue and
feedback on challenges faced by the
animal agriculture industry and
practicing veterinarians as FDA
implements its initiative for the
judicious use of medically important
antimicrobials in medicated feed or
drinking water of food-producing
animals. Particular emphasis will be
placed on challenges faced by animal
producers in areas that may lack access
to adequate veterinary services. The
meetings are jointly sponsored by FDA
and the U.S. Department of
Agriculture’s (USDA’s) Animal and
Plant Health Inspection Service
(APHIS).
DATES: See the SUPPLEMENTARY
INFORMATION section for meeting
VerDate Mar<15>2010
14:43 Mar 06, 2013
dates.
Jkt 229001
FOR FURTHER INFORMATION CONTACT:
Patricia Arnwine, Center for Veterinary
Medicine (HFV–6), Food and Drug
Administration, 7519 Standish Pl.,
Rockville, MD 20855; 240–276–9724;
FAX: 240–276–9101,
patricia.arnwine@fda.hhs.gov.
SUPPLEMENTARY INFORMATION:
Dates, Times, and Locations
• April 9, 2013, from 8:30 a.m. to
12:30 p.m., Western Kentucky
University–Carroll Knicely Conference
Center (Auditorium rm. 138), 2355
Nashville Rd., Bowling Green, KY
42101; 270–745–1908; FAX: 270–745–
1911; https://www.wku.edu/.
• April 23, 2013, from 8:30 a.m. to
12:30 p.m., Evergreen State College
(Library 4300), 2700 Evergreen Pkwy.
NW., Olympia WA 98505; 360–867–
6192 or 6000; https://
www.evergreen.edu/home.htm.
• May 8, 2013, from 8:30 a.m. to
12:30 p.m., The Natural Resource
Research Center, USDA Animal and
Plant Health & Inspection Service,
Veterinary Services, Centers for
Epidemiology & Animal Health, 2150
Centre Ave. (Building B, Gray’s Peak
Conference Rooms A & B), Fort Collins,
CO 80526–8117; 970–494–7200; FAX:
970–472–2668; https://
www.aphis.usda.gov/about_aphis/
programs_offices/veterinary_services/
ceah.shtml.
• May 21, 2013, from 8:30 a.m. to
12:30 p.m., Best Western Ramkota Hotel
& Conference Center (Amphitheater II),
920 West Sioux Ave., Pierre, SD 57501;
605–224–6877; FAX: 605–224–1042;
https://pierre.bwramkota.com/.
• June 4, 2013, from 8:30 a.m. to
12:30 p.m., Texas A&M University
(Memorial Student Center, rm. 2406A),
Joe Routt Boulevard and Houston Street,
College Station, TX 77840; 979–845–
8904; FAX: 979–845–2519; https://
www.tamu.edu/.
Oral Presentations: Interested persons
may make oral presentations on the
topic of the discussion of the meeting.
Oral presentations from the public
during the open public comment period
will be scheduled approximately:
• April 9, 2013, from 9:45 a.m. to 11
a.m. on the day of the meeting in
Bowling Green, KY;
• April 23, 2013, from 9:45 a.m. to 11
a.m. on the day of the meeting in
Olympia, WA;
• May 8, 2013, from 9:45 a.m. to 11
a.m. on the day of the meeting in Fort
Collins, CO;
• May 21, 2013, from 9:45 a.m. to 11
a.m. on the day of the meeting in Pierre,
SD; and
PO 00000
Frm 00039
Fmt 4703
Sfmt 4703
14801
• June 4, 2013, from 9:45 a.m. to 11
a.m. on the day of the meeting in
College Station, TX.
Although prior notification is not
required, it is recommended that those
desiring to make oral presentations
notify the contact person before the
meeting. In an effort to accommodate all
who desire to speak, time allotted for
each presentation may be limited.
Registration is not required for these
meetings; however, early arrival is
recommended because seating may be
limited. If you need special
accommodations due to a disability,
please contact FDA (see FOR FURTHER
INFORMATION CONTACT) at least 7 days in
advance.
Comments: Regardless of attendance
at the public meetings, interested
persons may submit either electronic or
written comments regarding the topics
to be discussed at these meetings.
Submit electronic comments to https://
www.regulations.gov. Submit written
comments to the Division of Dockets
Management (HFA–305), Food and Drug
Administration, 5630 Fishers Lane, rm.
1061, Rockville, MD 20852. It is only
necessary to send one set of comments.
Identify comments with the docket
number found in brackets in the
heading of this document. Received
comments may be seen in the Division
of Dockets Management between 9 a.m.
and 4 p.m., Monday through Friday.
The docket will remain open for written
or electronic comments for 60 days
following the last of these five meetings.
FDA is concerned about the risk that
antimicrobial resistance poses to public
health from the use of medically
important antimicrobial drugs in foodproducing animals. Over the past
several years, FDA’s Center for
Veterinary Medicine has developed a
policy framework for decreasing this
public health risk through the
application of concepts of judicious use.
Among these concepts, FDA believes
that it is important to include veterinary
oversight in the use of medically
important antimicrobial drugs in the
feed or water of food-producing animals
to assure the drugs’ appropriate and
judicious use.
Until the early 1990s, most
antimicrobial drugs were approved for
over-the-counter (OTC) use in foodproducing animals. However, since that
time increasing concerns about
antimicrobial resistance and evolving
understanding of the science related to
the issue have resulted in greater
scrutiny of the conditions under which
these drugs are approved. As a result,
since the early 1990s all new approvals
for antimicrobial drug products for use
in food-producing animals have been
E:\FR\FM\07MRN1.SGM
07MRN1
Agencies
[Federal Register Volume 78, Number 45 (Thursday, March 7, 2013)]
[Notices]
[Pages 14800-14801]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-05331]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Administration for Children and Families
Submission for OMB Review; Comment Request
Title: Community Services Block Grant (CSBG) Program Model Plan
Application.
OMB No.: 0970-0382.
Description: Sections 676 and 677 of the Community Services Block
Grant Act require States, including the District of Columbia and the
Commonwealth of Puerto Rico, Tribes, Tribal organizations and U.S.
territories applying for Community Services Block Grant (CSBG) funds to
submit an application and plan (Model Application Plan). The
application plan must meet statutory requirements prior to being funded
with CSBG funds. Applicants have the option to submit a detailed
application annually or biannually. Entities that submit a biannual
application must provide an abbreviated application the following year
if substantial changes to the initial application will occur. OMB
approval is being sought.
Respondents: State Governments, including the District of Columbia
and the Commonwealth of Puerto Rico, Tribal Governments, Tribal
Organizations, and U.S. territories.
Annual Burden Estimates
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Instrument Number of responses per hours per Total burden
respondents respondent response hours
----------------------------------------------------------------------------------------------------------------
Model State CSBG Application.................... 56 1 10 560
Model Indian Tribes & Tribal Organizations CSBG 30 1 10 300
Application....................................
----------------------------------------------------------------------------------------------------------------
Estimated Total Annual Burden Hours: 860.
Additional Information: Copies of the proposed collection may be
obtained by writing to the Administration for Children and Families,
Office of Planning, Research and Evaluation, 370 L'Enfant Promenade
SW., Washington,
[[Page 14801]]
DC 20447, Attn: ACF Reports Clearance Officer. All requests should be
identified by the title of the information collection. Email address:
infocollection@acf.hhs.gov.
OMB Comment: OMB is required to make a decision concerning the
collection of information between 30 and 60 days after publication of
this document in the Federal Register. Therefore, a comment is best
assured of having its full effect if OMB receives it within 30 days of
publication. Written comments and recommendations for the proposed
information collection should be sent directly to the following: Office
of Management and Budget, Paperwork Reduction Project, Fax: 202-395-
7285, Email: OIRA_SUBMISSION@OMB.EOP.GOV, Attn: Desk Officer for the
Administration for Children and Families.
Robert Sargis,
Reports Clearance Officer.
[FR Doc. 2013-05331 Filed 3-6-13; 8:45 am]
BILLING CODE 4184-01-P